Pharmacological evidence that neurotensin mediates prolactin-induced activation of tuberoinfundibular dopamine neurons

Neuroendocrinology

Volumn 68, Issue 2, 1998, Pages 71-76

  Hentschel, Kenneth ^a   Cheung, Sun ^a   Moore, Kenneth E ^a   Lookingland, Keith J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Catecholamine metabolites; Catecholamines; Median eminence; Neurotensin; Neurotensin antagonists; Prolactin

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; NEUROTENSIN; NEUROTENSIN RECEPTOR; PROLACTIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; FEMALE; HYPERPROLACTINEMIA; HYPOPHYSIS CELL; MALE; MEDIAN EMINENCE; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; RAT; TUBEROHYPOPHYSEAL TRACT;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ARCUATE NUCLEUS; BINDING, COMPETITIVE; DOPAMINE; DOPAMINE ANTAGONISTS; FEMALE; HALOPERIDOL; MALE; MEDIAN EMINENCE; NEURONS; NEUROTENSIN; PROLACTIN; PYRAZOLES; QUINOLINES; RATS; RATS, INBRED STRAINS; RECEPTORS, NEUROTENSIN; SEX FACTORS;

EID: 0031875389     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000054352     Document Type: Article

References (36)

1. Bjórklund A, Moore RY, Nobin A, Stenevi U: The organization of tuberohypophyseal and reticulo-infundibular catecholamine neuron systems in the rat brain. Brain Res 1973;51:171-191.
2. Ben-Jonathan N: Dopamine: A prolactin-inhibiting hormone. Endocr Rev 1985;6:564-589.
3. Moore KE, Lookingland KJ: Dopaminergic neuronal systems in the hypothalamus; in Bloom FE, Kupfer DJ (eds): Psychopharmacology: A Fourth Generation of Progress. New York, Raven Press, 1995, pp 245-256.
4. Demarest KT, Riegle GD, Moore KE: Prolactin-induced activation of tuberoinfundibular dopaminergic neurons: Evidence for both a rapid 'tonic' and a delayed 'induction' component. Neuroendocrinology 1984;38:467-475.
5. Demarest KT, Riegly GD, Moore KE: The rapid 'tonic' and the delayed 'induction' components of the prolactin-induced activation of tuberoinfundibular dopaminergic neurons following the systemic administration of prolactin. Neuroendocrinology 1986;43:291-299.
6. Moore KE, Demarest KT, Lookingland KJ: Stress, prolactin and hypothalamic dopaminergic neurons. Neuropharmacology 1987;26: 801-808.
7. Hökfelt T, Fuxe K: Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons. Neuroendocrinology 1972;9:100-122.
8. Selmanoff M: The lateral and medial median eminence: Distribution of dopamine, norepinephrine and luteinizing hormone-releasing hormone and the effect of prolactin on catecholamine turnover. Endocrinology 1981;108: 1716-1722.
9. Annunziato L, Moore KE: Prolactin in CSF selectively increases dopamine turnover in the median eminence. Life Sci 1978;22:2037-2042.
10. Moore KE, Riegle GD, Demarest KT: Effects of long-term treatment with estradiol and haloperidol on serum concentrations of prolactin and tuberoinfundibular dopaminergic neuronal activity; in MacLeod RM, Thorner MO, Scapagnini U (eds): Prolactin, Basic and Clinical Correlates. Fidia Research Series. Padova, Liviana Press, 1985, vol 1, pp 543-549.
11. Johnston CA, Demarest KT, Moore KE: Cycloheximide disrupts the prolactin-mediated stimulation of dopamine synthesis in tuberoinfundibular neurons. Brain Res 1980;195:236-240.
12. Gudelsky GA, Annunziato L, Moore KE: Localization of the site of the haloperidol-induced, prolactin-mediated increase of dopamine turnover in the median eminence: Studies in rats with complete hypothalamic deafferentations. J Neural Transm 1978;42:181-192.
13. Emson PC, Goedert M, Horsfield P, Rioux F, St Pierre S: The regional distribution and chromatographic characterisation of neurotensin-like immunoreactivity in the rat central nervous system. J Neurochem 1982;38:992-999.
14. Merchenthaler I, Lennard DE: The hypophysiotropic neurotensin-immunoreactive neuronal system of the rat brain. Endocrinology 1991; 129:2875-2880.
15. Alexander MJ: Dopamine neurons in the adult rat diencephalon express mRNA encoding high-affinity neurotensin receptor (abstract 586.9). Soc Neurosci Abstr 1997;23:1488.
16. Herbison AE, Hubbard JI, Sirett NE: Neurotensin excites neurons in the arcuate nucleus of the rat hypothalamus in vitro. Brain Res 1986; 364:391-395.
17. Lin J-Y, Pan J-T: Bombesin and neurotensin excite neurons in hypothalamic arcuate nucleus brain slices: An extracellular single-unit study. Brain Res Bull 1993;30:177-180.
18. Widerlov E, Kilts CD, Mailman RB, Nemeroff CB, McCown TJ, Prange AJ Jr, Breese GR: Increase in dopamine metabolites in rat brain by neurotensin. J Pharmacol Exp Ther 1982; 223:1-6.
19. Gudelsky GA, Berry SA, Meltzer HY: Neurotensin activates tuberoinfundibular dopamine neurons and increases serum corticosterone concentrations in the rat. Neuroendocrinology 1989;49:604-609.
20. Pan J-T, Tian Y, Lookingland KJ, Moore KE: Neurotensin-induced activation of hypothalamic dopaminergic neurons is accompanied by a decrease in pituitary secretion of prolactin and alpha-melanocyte-stimulating hormone. Life Sci 1992;50:2011-2017.
21. Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard J-C, Poncelet M, Guedet C, Heaulme M, Leyris R, Brouard A, Pelaprat D, Labbé-Jullié C, Mazella J, Soubrié P, Maffrand J-P, Rostène W, Kitabgi P, Le Fur G: Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci USA 1993;90:65-69.
22. Lookingland KJ, Jarry HD, Moore KE: The metabolism of dopamine in the median eminence reflects the activity of tuberoinfundibular neurons. Brain Res 1987;419:303-310.
23. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 2. New York, Academic Press, 1986.
24. Lookingland KJ, Moore KE: Dopamine receptor-mediated regulation of incertohypothalamic dopaminergic neurons in the male rat. Brain Res 1984;304:329-338.
25. Palkovits M: Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res 1973; 59:449-450.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin reagent. J Biol Chem 1951;193:265-275.
27. Chapin DS, Lookingland KJ, Moore KE: Effects of LC mobile phase composition on retention times for biogenic amines, and their precursors and metabolites. Curr Separations 1986;7:68-70.
28. Steel RGD, Torrie JH: Principles and Procedures of Statistics. New York, McGraw Hill, 1960.
29. Steinberg R, Brun P, Fournier M, Souilhac J, Rodier D, Mons G, Terranova JP, Le Fur G, Soubrié P: SR 48692, a non-peptide neurotensin receptor antagonist differentially affects neurotensin-induced behaviour and changes in dopaminergic transmission. Neuroscience 1994;59:921-929.
30. Castagliuolo I, Leeman SE, Bartolak-Suki E, Nikulasson S, Qiu B, Carraway RE, Pothoulakis C: A neurotensin antagonist, SR 48692, inhibits colonic responses to immobilization stress in rats. Proc Natl Acad Sci USA 1996;93: 12611-12615.
31. 3H]SR 48692, in the guinea pig brain. J Pharmacol Exp Ther 1995;273:1450-1458.
32. Le F, Cusack B, Richelson E: The neurotensin receptor: Is there more than one subtype? Trends Pharmacol Sci 1996;17:1-3.
33. Rostène WH, Alexander MJ: Neurotensin and neuroendocrine regulation. Front Neuroendocrinol 1997;18:155-173.
34. Marcos P, Corio M, Dubourg P, Tramu G: Reciprocal connections between neurotensin-and tyrosine hydroxylase-immunoreactive neurons in the mediobasal hypothalamus of the guinea pig. Brain Res 1996;715:63-70.
35. Hökfelt T, Everitt BJ, Theordorsson-Norheim E, Goldstein M: Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic, mesencephalic and medullary catecholamine neurons. J Comp Neurol 1984;222: 243-259.
36. Bachelet CM, Scarceriaux V, Rostène W, Pelaprat D: Evidence for neurotensin autoreceptors and relationship of neurotensin and its receptors with tyrosine hydroxylase-positive neurons in rat primary hypothalamic cultures. Eur J Neurosci 1997;9:1483-1487.